Literature DB >> 3688225

Models to interpret kinetic data in stable isotope tracer studies.

C Cobelli1, G Toffolo, D M Bier, R Nosadini.   

Abstract

In contrast to "weightless" radioactive tracers, stable isotope tracers have nonnegligible mass and are naturally present in the system, and the measured variable is a ratio of two isotopic species. These features do not allow stable isotopic tracer data analysis using straightforward analogy with radioactive tracer approaches, even though this practice is common. In this study, we present kinetic variables, models, and measurements for the analysis and interpretation of stable isotope tracer data. Assumptions and mathematical techniques for modeling the data when perturbation is both nonnegligible and negligible are discussed. Emphasis is placed on the rich information content of the dynamic portion of a stable isotope tracer curve and on the role of compartmental and noncompartmental modeling approaches for its interpretation. A presumed and commonly used analogy between the radioactive specific activity and stable isotopic enrichment is shown to be incorrect. We show that the proper analogue of specific activity is the tracer-to-tracee molar ratio. This variable is not a directly measurable one, but a formula is derived that allows its computation from the data. A method for reconstructing the time course in blood of the concentration component due to endogenous synthesis is presented. This allows measurement of the extent of the perturbation in the case where a nonweightless tracer is used. Special attention is given to data analysis originating from a multiple tracer experiment, a configuration necessary for studying more complex systems, e.g., the kinetics of interacting substrates.

Mesh:

Substances:

Year:  1987        PMID: 3688225     DOI: 10.1152/ajpendo.1987.253.5.E551

Source DB:  PubMed          Journal:  Am J Physiol        ISSN: 0002-9513


  25 in total

Review 1.  Studying apolipoprotein turnover with stable isotope tracers: correct analysis is by modeling enrichments.

Authors:  Rajasekhar Ramakrishnan
Journal:  J Lipid Res       Date:  2006-09-01       Impact factor: 5.922

2.  Alternative equations for whole-body protein synthesis and for fractional synthetic rates of proteins.

Authors:  Rajasekhar Ramakrishnan
Journal:  Metabolism       Date:  2007-11       Impact factor: 8.694

Review 3.  Expanding the concepts and tools of metabolic engineering to elucidate cancer metabolism.

Authors:  Mark A Keibler; Sarah-Maria Fendt; Gregory Stephanopoulos
Journal:  Biotechnol Prog       Date:  2012-10-18

4.  Metabolism of apoB lipoproteins of intestinal and hepatic origin during constant feeding of small amounts of fat.

Authors:  Chunyu Zheng; Katsunori Ikewaki; Brian W Walsh; Frank M Sacks
Journal:  J Lipid Res       Date:  2006-05-09       Impact factor: 5.922

5.  Effects of CETP inhibition on triglyceride-rich lipoprotein composition and apoB-48 metabolism.

Authors:  Margaret R Diffenderfer; Margaret E Brousseau; John S Millar; P Hugh R Barrett; Chorthip Nartsupha; Peter M Schaefer; Megan L Wolfe; Gregory G Dolnikowski; Daniel J Rader; Ernst J Schaefer
Journal:  J Lipid Res       Date:  2012-04-02       Impact factor: 5.922

6.  [Incorporation of 15N in VLDL and LDL: in vivo synthesis of apolipoprotein B in the post-absorptive and fasting state].

Authors:  P Schauder; J Arends; G Schäfer; K Langer; D M Bier
Journal:  Klin Wochenschr       Date:  1989-03-01

7.  Extended-release niacin alters the metabolism of plasma apolipoprotein (Apo) A-I and ApoB-containing lipoproteins.

Authors:  Stefania Lamon-Fava; Margaret R Diffenderfer; P Hugh R Barrett; Aaron Buchsbaum; Mawuli Nyaku; Katalin V Horvath; Bela F Asztalos; Seiko Otokozawa; Masumi Ai; Nirupa R Matthan; Alice H Lichtenstein; Gregory G Dolnikowski; Ernst J Schaefer
Journal:  Arterioscler Thromb Vasc Biol       Date:  2008-06-19       Impact factor: 8.311

8.  The effects of different plasma insulin concentrations on lipolytic and ketogenic responses to epinephrine in normal and type 1 (insulin-dependent) diabetic humans.

Authors:  A Avogaro; A Valerio; L Gnudi; A Maran; M Miola; E Duner; C Marescotti; E Iori; A Tiengo; R Nosadini
Journal:  Diabetologia       Date:  1992-02       Impact factor: 10.122

9.  Distinct metabolism of apolipoproteins (a) and B-100 within plasma lipoprotein(a).

Authors:  Margaret R Diffenderfer; Stefania Lamon-Fava; Santica M Marcovina; P Hugh R Barrett; Julian Lel; Gregory G Dolnikowski; Lars Berglund; Ernst J Schaefer
Journal:  Metabolism       Date:  2015-11-06       Impact factor: 8.694

10.  Ketone body kinetics in vivo using simultaneous administration of acetoacetate and 3-hydroxybutyrate labelled with stable isotopes.

Authors:  A Avogaro; R Nosadini; D M Bier; C Cobelli; G Toffolo; A Doria; A Valerio; H Christopherson
Journal:  Acta Diabetol Lat       Date:  1990 Jan-Mar
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.